Back to feed
PLXProtalix BioTherapeutics, Inc.
CIK 0001006281 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Institution-led2/5 sources
26/100
Recent disclosures · timeline
- 8-K5.079.013d ago
Submission of matters to a shareholder vote
Price · PLX
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Material events · 8-K
PLX corporate events · live SEC data- 5.079.013d ago
Submission of matters to a shareholder vote
Form 8-K — items reported: 5.07 Submission of matters to a shareholder vote; 9.01 Financial statements and exhibits.
Item 5.07 · Submission of matters to a shareholder vote +1 moreView 8-K on EDGAR ↗
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data6 funds hold$13.54M reported valueNet accumulating(4 adding · 3 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 3,616,962 | $7.85M | 0.0% | Trim-1% |
| Renaissance Technologies LLC Jim Simons (founder) | 1,224,800 | $2.66M | 0.1% | Trim-3% |
| State Street Corp | 972,815 | $2.11M | 0.0% |
Recent insider transactions
No insider transactions recorded for PLX.